For patients undergoing a radical cystectomy, staying active before and after surgery is key, Dr. Janet Kukreja explained. For patients with bladder cancer undergoing radical cystectomy (the surgical ...
Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based ...
Enfortumab vedotin plus pembrolizumab significantly improves EFS and OS in cisplatin-ineligible MIBC patients, offering a new treatment option. The EV-303 trial is the first to show systemic treatment ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...
Frailty-associated gut dysbiosis significantly increases the risk for gastrointestinal complications following robot-assisted ...
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder ...
From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...
Discover a study on SIP-BMG for bladder neck stenosis, revealing over 90% success and lasting improvements in urinary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback